TP53 and colorectal carcinoma: Moreover, the tumour‐suppressive role of METTL14 in p53‐wild‐type CRC cells, while not significantly affecting p53‐mutant or p53‐null CRC cells, highlights the influence of tumour heterogeneity on m6A regulators' roles.72